BNP Paribas Financial Markets’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$570K Sell
31,301
-57,509
-65% -$1.05M ﹤0.01% 2498
2025
Q1
$1.76M Buy
88,810
+12,038
+16% +$239K ﹤0.01% 1747
2024
Q4
$1.32M Sell
76,772
-674,016
-90% -$11.6M ﹤0.01% 1920
2024
Q3
$15M Buy
750,788
+85,250
+13% +$1.7M 0.01% 678
2024
Q2
$7.44M Sell
665,538
-67,382
-9% -$753K 0.01% 857
2024
Q1
$4.84M Buy
732,920
+442,315
+152% +$2.92M ﹤0.01% 1051
2023
Q4
$1.31M Buy
290,605
+96,653
+50% +$437K ﹤0.01% 1619
2023
Q3
$694K Buy
193,952
+27,995
+17% +$100K ﹤0.01% 1913
2023
Q2
$612K Sell
165,957
-255,759
-61% -$944K ﹤0.01% 1904
2023
Q1
$1.4M Buy
421,716
+235,185
+126% +$778K ﹤0.01% 1567
2022
Q4
$724K Sell
186,531
-53,122
-22% -$206K ﹤0.01% 1752
2022
Q3
$582K Buy
239,653
+197,752
+472% +$481K ﹤0.01% 2230
2022
Q2
$83K Buy
41,901
+40,717
+3,439% +$80.6K ﹤0.01% 2780
2022
Q1
$2.17K Hold
1,184
﹤0.01% 3327
2021
Q4
$1.67K Sell
1,184
-204
-15% -$288 ﹤0.01% 3362
2021
Q3
$1.57K Sell
1,388
-185
-12% -$209 ﹤0.01% 3227
2021
Q2
$2.52K Sell
1,573
-8,214
-84% -$13.1K ﹤0.01% 3256
2021
Q1
$17.2K Sell
9,787
-3,163
-24% -$5.57K ﹤0.01% 3213
2020
Q4
$25.3K Sell
12,950
-1,478
-10% -$2.88K ﹤0.01% 3141
2020
Q3
$34.5K Buy
14,428
+11,482
+390% +$27.4K ﹤0.01% 3011
2020
Q2
$8.63K Sell
2,946
-18,122
-86% -$53.1K ﹤0.01% 3137
2020
Q1
$60.7K Buy
21,068
+15,219
+260% +$43.8K ﹤0.01% 2841
2019
Q4
$23.4K Sell
5,849
-521
-8% -$2.08K ﹤0.01% 3284
2019
Q3
$28.3K Buy
6,370
+3,981
+167% +$17.7K ﹤0.01% 3150
2019
Q2
$9.25K Sell
2,389
-1,726
-42% -$6.68K ﹤0.01% 3489
2019
Q1
$15.6K Buy
+4,115
New +$15.6K ﹤0.01% 3363